Antibody Trial Evaluates Patient Tolerance
Phase 1B of a clinical trial is evaluating patient tolerance for a drug candidate. Patients are divided into two groups, one receiving the antibody and one without.
Topics
Developing
- 863d Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore.
- 863d Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur.
- 863d Excepteur sint occaecat cupidatat non proident, sunt in culpa qui officia deserunt mollit anim id est.
- 863d Sed ut perspiciatis unde omnis iste natus error sit voluptatem accusantium doloremque laudantium.
Sources · 7 independent
France Culture
“le but était d'évaluer la tolérance candidat médicament. de patient réparti en deux groupes avec et sans cet anticorps. En clair, personne ici ne parle de traitement révolutionnaire ni de guérison”
Unlock the full story
Get a Pro subscription or above to see the live story progression and the full list of independent sources confirming each event as they happen.
Log in to upgrade